Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC
NCT05287256Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- May 2022
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of delta-8-tetrahydrocannabinol (10 arms), sponsored by Johns Hopkins University. Primary endpoint: Drug Effect Questionnaire. Started May 2022; status: completed.
02
Drugs
delta-8-tetrahydrocannabinol
Beyond the preview
Go deeper on NCT05287256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05287256.